Prime Therapeutics LLC

1305 Corporate Center Dr
Eagan, MN 55121

Prime Therapeutics LLC News

PRIME THERAPEUTICS LLC: Analyzing integrated medical, pharmacy drug claims essential in forecasting eculizumab’s (Soliris®) cost

A study by pharmacy benefit manager Prime Therapeutics LLC (Prime) designed to forecast the potential use and cost of eculizumab (Soliris®), a drug billed through the medical benefit, to treat Myasthenia Gravis (MG) found the expanded use could lead to nearly a twofold increase in Soliris forecasted cost trend in 2018 and beyond. Read More »